🔗 Permalink

Inventor profile of:

Isabelle RICHARD

City:

Corbeil Essonnes

Country:

France

Published Applications:

22

Last publication date:

2025-06-26

Top Assignees for applications by Isabelle RICHARD

The entities that hold a legal rights for patent applications filed by inventor RICHARD Isabelle:

GENETHON 9 Evry, France
Universite D'Evry Val D'Essonne 7 Evry, France
Genethon 7 Evry-Courcouronnes, France
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE 5 PARIS, France
Institut National de la Sante et de la Recherche Medicale 5 Paris, France
INSERM INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) 3 Paris, France
Universite d'Evry val d'Essonne 2 Evry-Courcouronnes, France
Centre National de la Recherche Scientifique 1 , France
Genethon 1 Paris, France
Genethon 1 , France

Recent patent applications by RICHARD Isabelle

Isabelle RICHARD from Corbeil Essonnes, FR has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-06-26

US20250205247A1

Human necessities

USE OF BAZEDOXIFENE FOR INCREASING MUSCLE SURVIVAL

#2 | 2024-06-27

US20240209030A1

Chemistry; metallurgy

Peptide-Modified AAV Capsid

#3 | 2023-10-26

US20230338369A1

Human necessities

COMBINATION OF A PROTEASOME INHIBITOR AND A HDAC INHIBITOR AND ITS USE FOR THE TREATMENT OF GENETIC DISEASES LINKED TO A PROTEIN CONFORMATIONAL DISORDER

#4 | 2023-10-12

US20230321277A1

Human necessities

NOVEL POLYNUCLEOTIDES ENCODING A HUMAN FKRP PROTEIN

#5 | 2023-09-07

US20230277686A1

Human necessities

A NOVEL MUSCLE-SPECIFIC PROMOTER

#6 | 2023-09-07

US20230277540A1

Human necessities

Treatment of Dilated Cardiomyopathies

#7 | 2023-08-31

US20230270885A2

Human necessities

GENE THERAPY EXPRESSION SYSTEM ALLEVIATING CARDIAC TOXICITY OF FKRP

#8 | 2023-08-24

US20230265427A1

Chemistry; metallurgy

Treatment of Genetic Dilated Cardiomyopathies

#9 | 2023-08-17

US20230256117A1

Human necessities

GENE THERAPY EXPRESSION SYSTEM ALLOWING AN ADEQUATE EXPRESSION IN THE MUSCLES AND IN THE HEART OF SGCG

#10 | 2023-08-10

US20230250450A1

Chemistry; metallurgy

NRF2 Activator for Use in Treating Dilated Cardiomyopathies

#11 | 2023-07-13

US20230220391A1

Chemistry; metallurgy

CILP-1 Inhibitors for Use in the Treatment of Dilated Cardiomyopathies

#12 | 2022-11-24

US20220370640A1

Human necessities

GENE THERAPY EXPRESSION SYSTEM ALLEVIATING CARDIAC TOXICITY OF FKRP

#13 | 2022-06-30

US20220204574A1

Chemistry; metallurgy

PRODUCTION OF LARGE-SIZED QUASIDYSTROPHINS USING OVERLAPPING AAV VECTORS

#14 | 2021-11-04

US20210338837A1

Human necessities

Synthetic polynucleotides encoding a human FKRP protein

#15 | 2018-09-13

US20180256752A1

Human necessities

Selective gene therapy expression system

#16 | 2016-11-17

US20160334417A1

Methods for diagnosing or monitoring muscular dystrophies

#17 | 2016-03-03

US20160058890A1

Human necessities

Selective gene therapy expression system

#18 | 2015-05-21

US20150141361A1

Human necessities

Use of epigenome-modifying compounds for the treatment of genetic muscular diseases linked to a protein-conformational disorder

#19 | 2013-07-04

US20130171172A1

Human necessities

CALPAIN-3 INHIBITORS FOR TREATING MUSCULAR DYSTROPHIES AND CARDIOMYOPATHIES

#20 | 2013-02-07

US20130035353A1

Human necessities

Drugs for the treatment of sarcogylcanopathies

#21 | 2010-10-21

US20100266551A1

Chemistry; metallurgy

ADENO-ASSOCIATED VIRAL VECTORS FOR THE EXPRESSION OF DYSFERLIN

#22 | 2010-01-14

US20100010036A1

Human necessities

Drugs for the treatment of sarcoglycanopathies

InventorID:

80036 ⎘